Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — Subchondral bone lesions can usually be managed nonoperatively. However, once collapse occurs ...
Oral vascular lesions, encompassing a range of benign anomalies such as venous lakes and haemangiomas, represent both functional and cosmetic challenges for affected individuals. Advances in laser ...
Over 58 million Americans have actinic keratosis, a skin condition caused by damage from the sun’s ultraviolet (UV) rays. With this condition, you develop scaly, discolored spots called actinic ...
A viewer says they have some skin lesions on their neck and back that their dermatologist is treating with liquid nitrogen. They say this treatment hurts, and they're looking for other options. Doctor ...
While Multiple Sclerosis (MS) doesn’t cause skin lesions, some aspects of MS or MS treatment can be associated with an increased risk of skin lesions, hives, and other skin problems. Treatment options ...
Please provide your email address to receive an email when new articles are posted on . Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary ...
HPV vaccination alongside surgical treatment for cervical lesions may reduce risk of further disease
Giving women the human papillomavirus (HPV) vaccine around the time they have surgery for precancerous cervical lesions might lead to a reduction in the risk of lesions returning as well as other ...
Calcinosis cutis is a condition where calcium salts are deposited in your skin. It can happen for a variety of reasons, and it often presents differently in different cases. Idiopathic. This type ...
Kaposi sarcoma (KS) is a rare cancer that can cause skin lesions on a person’s feet. The lesions may appear as purple, reddish-blue, or brown marks on the skin, and people may mistake them for other ...
Clinical Trials Arena on MSN
Zenas’ MS drug reduces new brain lesion formation by 95% in Phase II trial
If approved, Zenas will enter the RMS market, which is currently dominated by anti-CD20 antibodies like Roche’s Ocrevus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results